You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Details for Patent: 9,522,155


✉ Email this page to a colleague

« Back to Dashboard


Title:Synthetic bile acid compositions and methods
Abstract: Bile acids and related compositions and methods of synthesis and use. More specifically, deoxycholic acid and related compositions, said compositions being free of all moieties of animal origin and free of pyrogenic moieties.
Inventor(s): Moriarty; Robert M. (Michiana Shores, IN), David; Nathaniel E. (Los Angeles, CA), Mahmood; Nadir Ahmeduddin (Calabasas, CA)
Assignee: KYTHERA BIOPHARMACEUTICALS, INC. (Calabasas, CA)
Filing Date:Sep 30, 2014
Application Number:14/503,273
Claims:1. A composition comprising about 0.1% w/v to about 2% w/v deoxycholic acid (DCA): ##STR00023## or a pharmaceutically acceptable salt thereof, wherein the DCA comprises a synthetic side chain of formula: ##STR00024## and at least one pharmaceutically acceptable excipient and/or carrier.

2. A method for removal of fat deposits in a mammal comprising administering to the mammal in need thereof a therapeutically effective amount of a composition comprising DCA ##STR00025## or a pharmaceutically acceptable salt thereof, wherein the DCA comprises a synthetic side chain of formula: ##STR00026## and at least one pharmaceutically acceptable excipient and/or carrier.

3. The method of claim 2, wherein the composition comprises about 0.1% w/v to about 2% w/v DCA or a pharmaceutically acceptable salt thereof.

4. The method of claim 2, wherein the composition further comprises up to 5% w/v phosphatidylcholine.

5. The method of claim 2, wherein the composition does not contain phosphatidylcholine.

6. A syringe or syringe-loadable container comprising a composition comprising DCA: ##STR00027## or a pharmaceutically acceptable salt thereof, wherein the DCA comprises a synthetic side chain of formula: ##STR00028## and at least one pharmaceutically acceptable excipient and/or carrier.

7. The syringe or syringe-loadable container of claim 6, wherein the composition comprises about 0.1% w/v to about 2% w/v DCA or a pharmaceutically acceptable salt thereof.

8. The syringe or syringe-loadable container of claim 6, wherein the composition further comprises up to 5% w/v phosphatidylcholine.

9. The syringe or syringe-loadable container of claim 6, wherein the composition does not contain phosphatidylcholine.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.